TR201005241A1 - Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. - Google Patents
Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.Info
- Publication number
- TR201005241A1 TR201005241A1 TR2010/05241A TR201005241A TR201005241A1 TR 201005241 A1 TR201005241 A1 TR 201005241A1 TR 2010/05241 A TR2010/05241 A TR 2010/05241A TR 201005241 A TR201005241 A TR 201005241A TR 201005241 A1 TR201005241 A1 TR 201005241A1
- Authority
- TR
- Turkey
- Prior art keywords
- controlled release
- solution formulation
- pregabalin
- pregabalin solution
- formulation
- Prior art date
Links
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title abstract 3
- 229960001233 pregabalin Drugs 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000499 gel Substances 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 229940100688 oral solution Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Buluş midede jelleşen ve kontrollü salım sağlayan oral solüsyon formülasyonu olup, pregabalin veya pregabalinin farmasötik olarak kabul edilebilir bir tuzu ile jelleştirici ajan içermektedir.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/05241A TR201005241A1 (tr) | 2010-05-25 | 2010-06-29 | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. |
EP11167335A EP2389935A1 (en) | 2010-05-25 | 2011-05-24 | Controlled-Release oral Solution Formulations of Pregabalin |
US13/115,725 US20110294887A1 (en) | 2010-05-25 | 2011-05-25 | Controlled-release solution formulations of pregabalin |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201004139 | 2010-05-25 | ||
TR201005145 | 2010-06-25 | ||
TR2010/05241A TR201005241A1 (tr) | 2010-05-25 | 2010-06-29 | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201005241A1 true TR201005241A1 (tr) | 2012-01-23 |
Family
ID=44225825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2010/05241A TR201005241A1 (tr) | 2010-05-25 | 2010-06-29 | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. |
Country Status (3)
Country | Link |
---|---|
US (1) | US20110294887A1 (tr) |
EP (1) | EP2389935A1 (tr) |
TR (1) | TR201005241A1 (tr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015063140A1 (en) * | 2013-10-30 | 2015-05-07 | Pharnext | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level |
CN113616591B (zh) * | 2021-09-03 | 2023-05-23 | 贝克诺顿(浙江)制药有限公司 | 一种普瑞巴林口服溶液及制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007052125A2 (en) * | 2005-11-02 | 2007-05-10 | Pfizer Products Inc. | Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
DE102007019071A1 (de) * | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
WO2009066325A1 (en) * | 2007-11-23 | 2009-05-28 | Lupin Limited | Controlled release pharmaceutical compositions of pregabalin |
WO2010143052A1 (en) * | 2009-06-12 | 2010-12-16 | Micro Labs Limited | Novel pharmaceutical compositions containing pregabalin |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5102666A (en) * | 1990-09-11 | 1992-04-07 | Oramed, Inc. | Calcium polycarbophil controlled release composition and method |
HU228771B1 (en) | 1998-05-15 | 2013-05-28 | Warner Lambert Co | Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
GB9910212D0 (en) * | 1999-05-05 | 1999-06-30 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
CZ299755B6 (cs) * | 2001-05-25 | 2008-11-12 | Warner-Lambert Company Llc | Kapalná farmaceutická kompozice obsahující analoggama-aminomáselné kyseliny, zpusob její prípravy a použití |
US20040010034A1 (en) * | 2002-07-10 | 2004-01-15 | Ciociola Arthur A. | Gastrointestinal compositions |
EP1543831A1 (en) * | 2003-12-18 | 2005-06-22 | Pfizer GmbH Arzneimittelwerk Gödecke | Pregabalin composition |
CA2603129A1 (en) * | 2005-04-06 | 2006-10-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of pregabalin |
WO2008008120A1 (en) | 2006-07-14 | 2008-01-17 | Fmc Corporation | Solid form |
WO2008140460A1 (en) | 2007-05-16 | 2008-11-20 | Fmc Corporation | Solid form |
WO2008140459A1 (en) | 2007-05-16 | 2008-11-20 | Fmc Corporation | Solid form |
CL2008003800A1 (es) * | 2007-12-21 | 2010-01-22 | Synthon Bv | Sal de acido sulfonico de pregabalina, procedimiento de preparacion, composicion farmaceutica, util para tratar trastornos neuropsiquiatricos, esquizofrenia, epilepsia, fibromialgia, trastorno de ansiedad generalizada, trastorno de panico y fobia social y dolor por ejemplo dolor neuropatico. |
US8329750B2 (en) * | 2008-02-11 | 2012-12-11 | Depomed, Inc. | Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage form |
-
2010
- 2010-06-29 TR TR2010/05241A patent/TR201005241A1/tr unknown
-
2011
- 2011-05-24 EP EP11167335A patent/EP2389935A1/en not_active Withdrawn
- 2011-05-25 US US13/115,725 patent/US20110294887A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007052125A2 (en) * | 2005-11-02 | 2007-05-10 | Pfizer Products Inc. | Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
DE102007019071A1 (de) * | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
WO2009066325A1 (en) * | 2007-11-23 | 2009-05-28 | Lupin Limited | Controlled release pharmaceutical compositions of pregabalin |
WO2010143052A1 (en) * | 2009-06-12 | 2010-12-16 | Micro Labs Limited | Novel pharmaceutical compositions containing pregabalin |
Also Published As
Publication number | Publication date |
---|---|
EP2389935A1 (en) | 2011-11-30 |
US20110294887A1 (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020010607A (es) | Compuestos y metodos para inhibir el transporte de fosfato. | |
UA111717C2 (uk) | Склад для перорального введення і ліпофільні солі метилналтрексону | |
EA201390804A1 (ru) | Лекарственная форма лакозамида для приема один раз в сутки | |
MX358716B (es) | Composiciones estables para el cuidado bucal que comprenden un aminoácido básico , una sal de estroncio y una fuente de ion fluoruro y usos de las mismas. | |
MX2011011109A (es) | Formulaciones orales de bendamustina. | |
MX347105B (es) | Composiciones farmaceuticas que comprenden hidromorfona y naloxona. | |
TR201107481A1 (tr) | Vildagliptinin efervesan formülasyonları. | |
EA201270728A1 (ru) | Пуриновые соединения | |
TR201001417A1 (tr) | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu | |
TR201005241A1 (tr) | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. | |
PH12014501304B1 (en) | Oral care compositions | |
IN2015DN04074A (tr) | ||
EA201201329A1 (ru) | Новая композиция для лечения эссенциальной тромбоцитемии | |
TR201007926A1 (tr) | Prasugrel tablet formülasyonları. | |
TR201001862A1 (tr) | Kontrollü salım gerçekleştiren pramipeksol formülasyonları. | |
TR201101809A1 (tr) | Vildagliptin ve glimepirid kombinasyonları. | |
TR200906506A2 (tr) | Telmisartan içeren katı dozaj formları. | |
EA201590732A1 (ru) | Диспергируемая таблетка | |
TR201009399A2 (tr) | Hızlı çözünen efervesan rosuvastatin formülasyonları. | |
TR201102857A2 (tr) | Telmisartan ve diüretik kombinasyonunun farmasötik formülasyonları. | |
TR201100151A2 (tr) | İbandronate formülasyonu. | |
TR200906322A2 (tr) | Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. | |
TR201005419A2 (tr) | Valsartan içeren farmasötik bileşim. | |
EA201270727A1 (ru) | Пуриновые соединения | |
TR201107563A1 (tr) | Vildagliptin ve gliklazid kombinasyon kompozisyonu. |